About

Publications While At HealthPartners

selected publications

Journal Article

Losartan improves memory, neurogenesis and cell motility in transgenic Alzheimer's mice. 

Pharmaceuticals (Basel, Switzerland). 2021

Antifibrotic effects of amyloid-beta and Its loss in cirrhotic liver. 

Cells. 2020

Cell motility and migration as determinants of stem cell efficacy. 

EBioMedicine. 2020

Intranasal losartan decreases perivascular beta amyloid, inflammation, and the decline of neurogenesis in hypertensive rats. 

Neurotherapeutics. 2019

Intranasal delivery of therapeutic neural stem cells to target intracerebral glioma

2015

Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease. 

Cell Transplantation. 2014

Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. 

Rejuvenation research. 2011

Intranasal delivery of stem cells and genetically engineered cells to the brain. 

Drug Deliv Technol. 2010

Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease. 

Rejuvenation research. 2010

Intranasal delivery of cells to the brain. 

European Journal of Cell Biology. 2009

Review

Intranasal treatment of central nervous system dysfunction in humans [review]. 

Pharmaceutical Research. 2013

Contact

full name

L. Danielyan

Quick Info

 

Collaboration

Co-author network

Map of science